What is Eurofins Scientific SE (ERF)?

Eurofins Scientific SE (ERF) is a Stock on NASDAQ. The last price is Lang & Schwarz when we have a quote. Charts stay delayed daily prices.

What is the ISIN of ERF?

The ISIN for Eurofins Scientific SE (ERF) is FR0014000MR3. It trades on NASDAQ.

Is this live market data?

The displayed quote defaults to Lang & Schwarz. NASDAQ and the charts are delayed daily prices. Not investment advice.

How do I research ERF in Blinx?

Open the terminal and ask Blinx about ERF: business overview, recent price action, valuation, and what to watch next. Tape is the public delayed chart; the terminal adds live data and portfolio context.

ERF · Eurofins Scientific SE — Tape

All tape

E

ERF NASDAQ

10:56 PM

Eurofins Scientific SE has released a disclosure regarding director/PDMR shareholding. The transaction comes alongside a market capitalization of approximately 4.10 billion and an FY revenue of 1,694,333,000. Currently, the company trades at a PE ratio of 9.30, supported by an EPS TTM of 2.16 and an FCF yield of 9.41%.

Based on businesswire.com

1D1 day

5D5 days

1M1 month

6M6 months

YTDYear to date

1Y1 year

5Y5 years

AllAll time

businesswire.comSep 1, 06:48 AM
Eurofins Scientific SE: Director/PDMR Shareholding
businesswire.comAug 31, 06:14 AM
Eurofins Scientific SE : Director/PDMR Shareholding
businesswire.comAug 27, 04:13 AM
Eurofins Scientific: Director/PDMR Shareholding
businesswire.comAug 19, 06:28 AM
Eurofins Scientific: Director/PDMR Shareholding
businesswire.comAug 14, 07:13 AM
Eurofins Scientific: Director/PDMR Shareholding
businesswire.comAug 7, 09:48 AM
Eurofins Scientific: Director/PDMR Shareholding

Market cap: 4.1B USD
Dividend yield: 2.40%
P/E: 9.30
Forward P/E: 5.57
Basic EPS (TTM): 2.16 USD
EPS (FY2026E): 3.61 USD
Net income (FY): 456.08M USD
Revenue (FY): 1.69B USD
Revenue (FY2026E): 1.87B USD
FCF yield (TTM): 9.41%
Shares float: —
Beta: —
52 week high
52 week low
Volume

Ticker: ERF
Exchange: NASDAQ
Type: Stock
Sector: —
ISIN: FR0014000MR3

Revenue & Net Income (5Y)

EPS & Growth (5Y)

Free Cash Flow (5Y)

Capital Returns

Operating & Net Margin (5Y)

CapEx vs. Free Cash Flow (5Y)

Capital Allocation (5Y)

R&D and SG&A Intensity (5Y)

EBITDA (5Y)

Cost of Revenue (5Y)

Market Cap (5Y)

Ask Blinx with professional market data, charts beside chat, and your portfolio context.

Ask Blinx about ERF

Default quotes are Lang & Schwarz. NASDAQ is the delayed listing price. Charts stay daily. Not investment advice.

ERF

E